{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:21:21Z","timestamp":1790832081936,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.molmed.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T12:37:50Z","timestamp":1566995870000},"page":"803-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies"],"prefix":"10.1016","volume":"25","author":[{"given":"Sridhar","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kyba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2019.07.004_bb0005","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2019.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","article-title":"The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma","volume":"94","author":"Lapidos","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2019.07.004_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/337176a0","article-title":"Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts","volume":"337","author":"Partridge","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0025","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/3167","article-title":"Is myoblast transplantation effective?","volume":"4","author":"Partridge","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096368979300200203","article-title":"Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy","volume":"2","author":"Tremblay","year":"1993","journal-title":"Cell Transplant."},{"key":"10.1016\/j.molmed.2019.07.004_bb0040","first-page":"119","article-title":"Myoblast transplantation: clinical trials and perspectives","volume":"24","author":"Vilquin","year":"2005","journal-title":"Acta Myol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0045","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nm0997-970","article-title":"The fate of individual myoblasts after transplantation into muscles of DMD patients","volume":"3","author":"Gussoni","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1083\/jcb.142.5.1257","article-title":"Development of approaches to improve cell survival in myoblast transfer therapy","volume":"142","author":"Qu","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0055","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1126\/science.1114758","article-title":"Direct isolation of satellite cells for skeletal muscle regeneration","volume":"309","author":"Montarras","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0060","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.mt.6300295","article-title":"Autologous transplantation of SM\/C-2.6(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice","volume":"15","author":"Ikemoto","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature05282","article-title":"Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs","volume":"444","author":"Sampaolesi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1082254","article-title":"Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts","volume":"301","author":"Sampaolesi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0075","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/292154a0","article-title":"Establishment in culture of pluripotential cells from mouse embryos","volume":"292","author":"Evans","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0085","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","article-title":"Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells","volume":"78","author":"Martin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2019.07.004_bb0090","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0115","doi-asserted-by":"crossref","first-page":"518135","DOI":"10.1155\/2014\/518135","article-title":"Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy","volume":"2014","author":"de Rham","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.molmed.2019.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-014-9574-4","article-title":"Banking on iPSC \u2013 is it doable and is it worthwhile","volume":"11","author":"Solomon","year":"2015","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.molmed.2019.07.004_bb0125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-X","article-title":"Expression of a single transfected cDNA converts fibroblasts to myoblasts","volume":"51","author":"Davis","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(86)90507-6","article-title":"Transfection of a DNA locus that mediates the conversion of 10T1\/2 fibroblasts to myoblasts","volume":"47","author":"Lassar","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0135","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/mt.2012.188","article-title":"Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation","volume":"20","author":"Goudenege","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0145","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/sj.emboj.7600346","article-title":"Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification","volume":"23","author":"Oustanina","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2019.07.004_bb0150","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1242\/dev.151035","article-title":"Making muscle: skeletal myogenesis in vivo and in vitro","volume":"144","author":"Chal","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.molmed.2019.07.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405943-6.00001-4","article-title":"Molecular and cellular regulation of skeletal myogenesis","volume":"110","author":"Comai","year":"2014","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0165","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","article-title":"PAX7 targets, CD54, Integrin \u03b19\u03b21, and SDC2, allow isolation of human ESC\/iPSC-derived myogenic progenitors","volume":"19","author":"Magli","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1533","article-title":"Derivation of engraftable skeletal myoblasts from human embryonic stem cells","volume":"13","author":"Barberi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051638","article-title":"Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells","volume":"7","author":"Awaya","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2019.07.004_bb0180","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stemcr.2013.10.007","article-title":"Derivation and FACS-mediated purification of PAX3+\/PAX7+ skeletal muscle precursors from human pluripotent stem cells","volume":"1","author":"Borchin","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.stemcr.2014.07.001","article-title":"Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells","volume":"3","author":"Shelton","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0190","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.stemcr.2018.04.002","article-title":"Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies","volume":"10","author":"van der Wal","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0195","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nbt.3297","article-title":"Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy","volume":"33","author":"Chal","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0200","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/nprot.2016.110","article-title":"Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro","volume":"11","author":"Chal","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molmed.2019.07.004_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stemcr.2017.04.022","article-title":"Expansion and purification are critical for the therapeutic application of pluripotent stem cell-derived myogenic progenitors","volume":"9","author":"Kim","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0210","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41467-017-01359-w","article-title":"MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors","volume":"8","author":"Giacomazzi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2019.07.004_bb0215","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1172\/JCI82735","article-title":"Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle","volume":"125","author":"Quattrocelli","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2019.07.004_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","article-title":"ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs","volume":"20","author":"Hicks","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0225","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","article-title":"Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.scr.2016.01.003","article-title":"Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR\/Cas9 technology","volume":"16","author":"Wu","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.molmed.2019.07.004_bb0235","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1038\/srep18759","article-title":"Generation and characterization of a MYF5 reporter human iPS cell line using CRISPR\/Cas9 mediated homologous recombination","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0240","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.celrep.2018.10.067","article-title":"A myogenic double-reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors","volume":"25","author":"Wu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0245","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2019.07.004_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0255","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.molmed.2019.07.004_bb0260","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2019.07.004_bb0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2019.07.004_bb0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0280","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0285","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/MCB.16.5.2164","article-title":"Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae","volume":"16","author":"Moore","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0290","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.2660260","article-title":"Altering the genome by homologous recombination","volume":"244","author":"Capecchi","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0295","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","article-title":"Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination","volume":"317","author":"Smithies","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0300","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tig.2008.08.007","article-title":"MMEJ repair of double-strand breaks (director\u2019s cut): deleted sequences and alternative endings","volume":"24","author":"McVey","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2019.07.004_bb0305","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/mt.2009.274","article-title":"Complete genetic correction of iPS cells from Duchenne muscular dystrophy","volume":"18","author":"Kazuki","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2019.07.004_bb0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2019.07.004_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2019.07.004_bb0325","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2016.40","article-title":"Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy","volume":"24","author":"Turan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0330","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1076-8","article-title":"Precise therapeutic gene correction by a simple nuclease-induced double-stranded break","volume":"568","author":"Iyer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0335","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/mt.2016.97","article-title":"Genome therapy of myotonic dystrophy type 1 iPS cells for development of autologous stem cell therapy","volume":"24","author":"Gao","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0340","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.ymthe.2018.09.003","article-title":"Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR\/Cas9","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0345","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1093\/nar\/gky548","article-title":"Efficient CRISPR\/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells","volume":"46","author":"Dastidar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2019.07.004_bb0350","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jnen\/62.9.951","article-title":"Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms","volume":"62","author":"Skuk","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0355","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.144.6.1113","article-title":"Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source","volume":"144","author":"Beauchamp","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0360","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0365","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0370","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0375","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0380","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0385","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2019.07.004_bb0390","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/stem.37","article-title":"Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine","volume":"27","author":"Knoepfler","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2019.07.004_bb0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5966\/sctm.2014-0202","article-title":"Concise review: making and using clinically compliant pluripotent stem cell lines","volume":"4","author":"Carpenter","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0400","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.07.004_bb0405","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0410","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.2926","article-title":"Concise review: laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury","volume":"37","author":"Tsuji","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2019.07.004_bb0415","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/d41586-018-05278-8","article-title":"\u2018Reprogrammed\u2019 stem cells approved to mend human hearts for the first time","volume":"557","author":"Cyranoski","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.07.004_bb0420","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/mt.2009.125","article-title":"A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy","volume":"17","author":"Tremblay","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2019.07.004_bb0425","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2019.07.004_bb0430","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491419301807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491419301807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:18:19Z","timestamp":1761463099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491419301807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1471491419301807"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2019.07.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}